Johnson & Johnson (Pty) Ltd has entered into a definite agreement to buy V-Wave Ltd. in a deal valued at potentially $1.7bn, which marks its second major deal in medtech this year, following the $13.1bn Shockwave Medical acquisition.
The New Jersey medtech giant announced on 20 August it would acquire Israel-based, privately held heart failure implant company V-Wave for an upfront payment of $600m, subject to customary
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?